What makes Direava's AI unique?

Developed with active surgeons, it offers a 'surgeon-centric' approach grounded in real clinical needs.

What is the GENIAC project?

A national initiative by METI and NEDO to strengthen Japan's generative AI foundation technologies.

When will this model be practical?

Currently in development and demonstration phase, aiming for future clinical implementation.

Is patient data secure?

Strict security measures are in place to protect medical data and ensure patient privacy.

Yes, engineers are actively being recruited. Contact info@direava.com for details.

AI News NQ Analysis

Direava Selected for Phase 4 of METI and NEDO's Domestic Generative AI Development Project 'GENIAC' — Advancing Development and Demonstration of a 'Future Prediction Model for Surgical Procedures' to Enhance Surgical Safety

Key facts

Direava Selected for Phase 4 of METI and NEDO's Domestic Generative AI Development Project 'GENIAC' — Advancing Development and Demonstration of a 'Future Prediction Model for Surgical Procedures' to Enhance Surgical Safety
Direava Inc. has been selected for Phase 4 of 'GENIAC,' a generative AI infrastructure development project led by Japan's Ministry of Economy, Trade and Industry (METI) and NEDO. The company will accelerate R&D on a 'Future Prediction Model for Surgical Procedures' aimed at reducing complications and enhancing medical safety.
Source: PR TIMES
Date: Thu Jun 18 2026 18:30:49 GMT+0900 (Japan Standard Time)

Direct answer

Direava Inc. has been selected for Phase 4 of 'GENIAC,' a generative AI infrastructure development project led by Japan's Ministry of Economy, Trade and Industry (METI) and NEDO. The company will accelerate R&D on a 'Future Prediction Model for Surgical Procedures' aimed at reducing complications and enhancing medical safety.

Citation: Direava Selected for Phase 4 of METI and NEDO's Domestic Generative AI Development Project 'GENIAC' — Advancing Development and Demonstration of a 'Future Prediction Model for Surgical Procedures' to Enhance Surgical Safety (Thu Jun 18 2026 18:30:49 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Thu Jun 18 2026 18:30:49 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

Direava Inc. has been selected for Phase 4 of 'GENIAC,' a generative AI infrastructure development project led by Japan's Ministry of Economy, Trade and Industry (METI) and NEDO. The company will accelerate R&D on a 'Future Prediction Model for Surgical Procedures' aimed at reducing complications and enhancing medical safety.

AI Analysis

Frequently Asked Questions

Q: What makes Direava's AI unique?: A: Developed with active surgeons, it offers a 'surgeon-centric' approach grounded in real clinical needs.
Q: What is the GENIAC project?: A: A national initiative by METI and NEDO to strengthen Japan's generative AI foundation technologies.
Q: When will this model be practical?: A: Currently in development and demonstration phase, aiming for future clinical implementation.
Q: Is patient data secure?: A: Strict security measures are in place to protect medical data and ensure patient privacy.
Q: Can engineers apply?: A: Yes, engineers are actively being recruited. Contact info@direava.com for details.